Skip to main content
Navigating the challenges of SMA.

Real challenges are involved in the management of SMA for you, your patients, and their caregivers

In untreated patients with SMA, motor function tended to improve in younger patients before beginning a period of decline from ages 5 to 13 years old1

Retrospective study data* showing age-related motor function in patients with SMA type 21

HFMSE score distribution from a longitudinal cohort.

Adapted with permission from Mercuri et al., 2019.

*Results from a single-center, retrospective study involving 73 patients in total, 28 of whom had more consistent longitudinal data and were assessed before the age of 5 years and had been followed up for ~5 years or longer. Patients enrolled in clinical trials were included until the baseline of the trial.1

Progressive loss of motor function with spinal muscular atrophy (SMA) was nonlinear1

•   Patients with SMA type 2 appeared stable over short intervals and children under 5 years old showed an overall trend to improve motor function
•  Steep decline typically occurs between ages 5 and 13, with relative stabilization after age 13
 
Understanding the trajectory of SMA can help improve outcomes1

•  Baseline Hammersmith Functional Motor Scale — Expanded (HFMSE) score predicted the rate and magnitude of decline
•  Patients with lower baseline scores experience earlier onset of scoliosis and a higher need for noninvasive ventilation
 
The annual loss in HFMSE score between the ages of 5 and 13 years old was about 2 points per year—each point lost may be considered clinically meaningful by patients and caregivers.1,2

HFMSE, Hammersmith Functional Motor Scale — Expanded; SMA, spinal muscular atrophy.

References: 1. Mercuri E, Lucibello S, Pera MC, et al. Long-term progression in type II spinal muscular atrophy: a retrospective observational study. Neurology. 2019;93(13):e1241-e1247. doi:10.1212/WNL.0000000000008166 2. Coratti G, Bovis F, Pera MC, et al. Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: an international study. Eur J Neurol. 2024;31:e16309. doi:10.1111/ene.16309